Synchron halts second-generation brain implant trial over performance problems
Synchron has paused enrollment in the multisite clinical trial of its newer, fully wireless Stentrode device after it failed to perform as expected in early participants. The Brooklyn-based brain-computer interface company says it voluntarily stopped enrollment after identifying a performance issue, and is simultaneously restructuring, cutting jobs and reducing its New York presence while expanding a San Diego team.